Skip to content

The Effects of Motherly on Postpartum Depression

Randomized Controlled Trial Testing the Effects of Motherly: a Standalone Smartphone Application Treatment for Women With Postpartum Depression

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05055674
Enrollment
264
Registered
2021-09-24
Start date
2021-09-30
Completion date
2022-07-31
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression

Keywords

postpartum depression, smartphone application, digital technology, maternal depression, mental health, mental disorder

Brief summary

Investigators will be test the efficacy of Motherly, a smartphone application (app) to treat depression in women with postpartum Depression. The Motherly app offers psychoeducation, mood and anxiety monitoring, several well-established psychological techniques (behavioral activation, cognitive restructuring, emotion regulation, stress management techniques, mindfulness and meditation, sleep hygiene), and helps mothers organize their medical appointments and keep track of their childrens' development. The efficacy of the Motherly app will be tested in a parallel two-arm randomized controlled trial. Participants will be randomly allocated to receive the Motherly app (intervention), or COMVC (active control), a smartphone app that delivers only psychoeducational content related to general mental health.

Detailed description

The postpartum period is strongly associated with increased risk for depression, with estimates of approximately 19% of women affected by the disorder. Psychosocial interventions such as home visiting programs and well-established psychological therapies are efficient to treat this condition but require a significant number of qualified trained professionals. However, financial and human resources to meet these demands are scarce in developing countries such as Brazil. Therefore, interventions delivered via electronic devices such as smartphones might fill this gap. Our objective is to test the efficacy of Motherly, a smartphone application (app) to treat depression in women with postpartum Depression. The Motherly app offers psychoeducation, mood and anxiety monitoring, several well-established psychological techniques (behavioral activation, cognitive restructuring, emotion regulation, stress management techniques, mindfulness and meditation, sleep hygiene), and helps mothers organize their medical appointments and keep track of their childrens' development. The efficacy of the Motherly app will be tested in a parallel two-arm randomized controlled trial. Two-hundred and sixty-four (N=264) 18-40-years-old women with postpartum depression will be to one of two groups: (1) intervention, which will have access to the Motherly app; or (2) active control, which will be given access to COMVC, a smartphone app that delivers only psychoeducational content on general mental health (COMVC means With You in Brazilian Portuguese). Duration of treatment will be four weeks, during which participants in both groups will be assessed at the beginning (baseline; T0), end (post treatment, T1), and 1 month after treatment completion (follow-up, T2).

Interventions

BEHAVIORALMotherly app

The Motherly app is organized in four different modules: 1) Library: a collection of brief texts on several topics related to health and pregnancy, 2) Health: journeys with varying degrees of interactivity designed to teach and engage participants in well-established psychological techniques (behavioral activation, cognitive restructuring, emotion regulation, stress management techniques, mindfulness and meditation, sleep hygiene techniques), 3) Pregnancy and motherhood: a module to help mothers keep track of their health care visits, medical exams, and their childrens' development, and 4) Profile: a module allowing participants to keep track of activities and goals completed in the Health module journeys, and to assess depression and anxiety symptoms with brief questionnaires, with results displayed graphically in a timeline and in the the form of short feedback texts.

BEHAVIORALCOMVC app

The COMVC displays over 30 brief psychoeducational videos on several topics related to general mental health, such as depression, anxiety, stress, sleep, problem solving techniques, among others. Psychoeducation is limited to video only (no interactivity). The content of these videos was developed by clinicians, researchers, and professors from the Psychiatry Department of the Medical School of the University of Sao Paulo and from the Federal University of Rio Grande do Sul. Mental health monitoring is delivered by means of brief questionnaires assessing depression and anxiety symptoms, which can be filled at users' discretion. Users' responses are displayed graphically in a timeline and they receive short feedback texts based on assessment results.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants will be aware of the intervention received, as well as investigators and professionals responsible for monitoring app usage during the study. The Outcome assessor will be blind to randomization status.

Intervention model description

Participants will be randomized to one of two groups: a) intervention, which will have access to the Motherly app; or b) active control, which will be given access to COMVC, a smartphone app that delivers only psychoeducational content.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Women who had given birth to a live baby in the past 12 months; * Age between 18-40 years; * Edinburgh Postnatal Depression Scale (EPDS) total score ≥ 10; * Depression symptoms present in the past 2 weeks; * Being literate; * Owing an Android or iPhone smartphone for personal use.

Exclusion criteria

* Intellectual, visual, or auditory deficiency; * Chronic diseases that prevent using smartphones or understanding how to use the apps; * Severe and/or chronic mental health diagnosis (schizophrenia or bipolar disorder).

Design outcomes

Primary

MeasureTime frameDescription
Depression symptomsPosttreatment (T1) 1 month after baselineChange in mean total scores between intervention and control groups in the Edinburgh Postnatal Depression Scale (EPDS) at Posttreatment (T1)

Secondary

MeasureTime frameDescription
Quality of Life: Mental HealthPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Mental Health Quality of Life mean scores between intervention and control groups in the 12-item health survey (SF-12) at Posttreatment (T1) and Follow-up (T2).
Difficult ChildPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Difficult Child mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).
AttachmentPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Attachment mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).
Parenting CompetencePosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Competence mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).
Sleep qualityPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in mean total scores between intervention and control groups in the Single-item Sleep Quality Scale at Posttreatment (T1) and Follow-up (T2).
Depression symptomsFollow-up (T2) 2 months after baselineChange in mean total scores between intervention and control groups in the Edinburgh Postnatal Depression Scale (EPDS)
Anxiety symptomsPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in mean total scores between intervention and control groups in the General Anxiety Disorder-7 (GAD-7)
Quality of Life: Physical HealthPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Physical Health Quality of Life mean scores between intervention and control groups in the 12-item health survey (SF-12) at Posttreatment (T1) and Follow-up (T2).
Parenting stressPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Total Stress mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).
Parental DistressPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Parental Distress mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).
Parent-child Dysfunctional InteractionPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in Parent-child Dysfunctional Interaction mean scores between intervention and control groups in the Parenting Stress Index (PSI) Short Form at Posttreatment (T1) and Follow-up (T2).

Other

MeasureTime frameDescription
Response to treatmentPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineComparison between intervention and control groups according to two categories: Very much improved, Much improved, Minimally improved vs. No change, Minimally worse, Much worse, Very much worse, in the Clinical Global Impression Index (CGI) scale.
Activation and avoidance behaviorsPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in mean scores between intervention and control groups in the The Behavioral Activation for Depression Scale-Short Form (BADS-SF) scale.
Reinforcement probability and environmental suppressionPosttreatment (T1) 1 month after baseline and Follow-up (T2) 2 months after baselineChange in mean scores between intervention and control groups in the Reward Probability Index (RPI) scale.

Contacts

Primary ContactDaniel Fatori, PhD
daniel.fatori@gmail.com+55 11 96162-6183
Backup ContactAdriana Argeu, Psychologist
adrianaargeu@gmail.com+55 11 98603-9059

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026